Granules India signs MoU with PharmaMatch

Granules India signs MOU with PharmaMatch
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset
moneycontrol.com

Home » News » Business

Dec 07, 2006, 01.25 PM | Source: Moneycontrol.com

Granules India signs MoU with PharmaMatch

Granules India signs MOU with PharmaMatch

Like this story, share it with millions of investors on M3

Granules India signs MoU with PharmaMatch

Granules India signs MOU with PharmaMatch

Post Your Comments

Share Cancel

PharmaMatch B.V. and Granules India Limited are pleased to announce the signing of a Memorandum of Understanding to develop, manufacture and market formulations in the European Market jointly. 

 

This arrangement will kick-off with the transfer of existing marketing authorizations by PharmaMatch to Granules for products like Paracetamol where Granules has the basic and the necessary skill sets to deliver the same.  This will use the upcoming finished dosage facility of Granules which is expected to be commissioned and fully operational by May 2007.

 

Commenting on the development, Mr. Irfan Vazirally, Executive Director, PharmaMatch India, said, “Granules has demonstrated excellent capabilities in pharmaceutical manufacturing and they are counting on their capabilities to take this forward in their new business of finished dosages as well”.

 

Mr. C. Krishna Prasad, Managing Director, Granules India Ltd. said, “PharmaMatch is a renowned finished dosage player in European Union and we expect this relationship to catapult Granules strongly into the European Market. We are expecting this development to expedite the approval process for the finished dosage facility in the European Union”. 

 

Sourced From: Adfactors Public Relations Pvt Ltd

Granules India stock price

On May 25, 2016, Granules India closed at Rs 126.70, down Rs 1.3, or 1.02 percent. The 52-week high of the share was Rs 164.45 and the 52-week low was Rs 75.55.


The company's trailing 12-month (TTM) EPS was at Rs 5.58 per share as per the quarter ended March 2016. The stock's price-to-earnings (P/E) ratio was 22.71. The latest book value of the company is Rs 25.27 per share. At current value, the price-to-book value of the company is 5.01.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Granules India signs MoU with PharmaMatch
New Member
0 Followers

Price when posted: BSE: Rs126.70 ( -1.02 % ), NSE: Rs. 126.85 ( -0.98 % )

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login